0001104659-25-121539.txt : 20251216 0001104659-25-121539.hdr.sgml : 20251216 20251216152044 ACCESSION NUMBER: 0001104659-25-121539 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251216 DATE AS OF CHANGE: 20251216 EFFECTIVENESS DATE: 20251216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Imbria Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001745672 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 830858012 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-542691 FILM NUMBER: 251574830 BUSINESS ADDRESS: STREET 1: 265 FRANKLIN STREET STREET 2: SUITE #1702 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 858-413-7899 MAIL ADDRESS: STREET 1: 265 FRANKLIN STREET STREET 2: SUITE #1702 CITY: BOSTON STATE: MA ZIP: 02110 D/A 1 primary_doc.xml X0708 D/A LIVE 0001745672 Imbria Pharmaceuticals, Inc. 265 FRANKLIN STREET SUITE #1702 BOSTON MA MASSACHUSETTS 02110 917-657-5069 DELAWARE None None Corporation true Alvin Shih 265 Franklin Street Suite #1702 Boston MA MASSACHUSETTS 02110 Executive Officer Director Andrew Levin 265 Franklin Street Suite #1702 Boston MA MASSACHUSETTS 02110 Director Luse Rebecca 265 Franklin Street Suite #1702 Boston MA MASSACHUSETTS 02110 Director Charles Dunn 265 Franklin Street Suite #1702 Boston MA MASSACHUSETTS 02110 Director Komal Joshi 265 Franklin Street Suite #1702 Boston MA MASSACHUSETTS 02110 Executive Officer Pavan Cheruvu 265 Franklin Street Suite #1702 Boston MA MASSACHUSETTS 02110 Director Ken Horne 265 Franklin Street Suite #1702 Boston MA MASSACHUSETTS 02110 Director Zina Affas Besse 265 Franklin Street Suite #1702 Boston MA MASSACHUSETTS 02110 Director Biotechnology Decline to Disclose 06b true 0001745672-25-000003 2025-03-10 false true false 0 144195814 66695817 77499997 false 10 0 0 0 false Imbria Pharmaceuticals, Inc. /s/ Komal Joshi Komal Joshi Secretary 2025-12-16